Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Family of anti-carcinoembryonic antigen chimeric antibodies

Family of anti-carcinoembryonic antigen chimeric antibodies

US Patent 5808033 · Granted Sep 15, 1998

Estimated economic value: $8,855,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

April and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2022
Methods of treatment using IL-23p19 monoclonal antibodies2022
Soluble hybrid Fcγ receptors and related methods2020
IL-23p19 monoclonal antibodies2019
Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodie2019
Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodie2017
IL-17A/F cross-reactive monoclonal antibodies and methods of using the same2017
Soluble hybrid Fcγ receptors and related methods2017
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antig2017
Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-2016